$2.35
N/A
Last update: Nov 2, 4:33 PM
Minerva Neurosciences Inc (NERV) Stock Price, Quote, News & History
NERVNASDAQ
Wall Street analysts revised their ratings for top stocks. Visit benzinga.com/analyst-stock-ratings for all changes, including upgrades and downgrades.
You can purchase shares of Minerva Neurosciences (NASDAQ:NERV) through any online brokerage.
Other companies in Minerva Neurosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Minerva Neurosciences has a consensus price target of $10.33.
The stock price for Minerva Neurosciences (NASDAQ: NERV) is $2.345 last updated November 2, 2026 at 4:33 PM EST.
There are no upcoming dividends for Minerva Neurosciences.
Minerva Neurosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Minerva Neurosciences.
Minerva Neurosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product...
